Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention | 16 | 2020 | 90 | 3.450 |
Why?
|
Pattern Recognition, Visual | 14 | 2021 | 37 | 2.860 |
Why?
|
Visual Perception | 11 | 2020 | 45 | 2.600 |
Why?
|
Reaction Time | 20 | 2020 | 94 | 2.520 |
Why?
|
Food, Fortified | 11 | 2023 | 22 | 2.500 |
Why?
|
Cognition | 11 | 2025 | 322 | 2.450 |
Why?
|
Iron | 9 | 2025 | 116 | 2.080 |
Why?
|
Models, Psychological | 11 | 2014 | 81 | 1.440 |
Why?
|
Learning | 5 | 2019 | 97 | 1.380 |
Why?
|
Auditory Perception | 3 | 2020 | 11 | 1.240 |
Why?
|
Perception | 5 | 2021 | 89 | 1.210 |
Why?
|
Illusions | 2 | 2021 | 4 | 1.130 |
Why?
|
Brain | 7 | 2025 | 739 | 1.110 |
Why?
|
Cues | 6 | 2020 | 40 | 1.080 |
Why?
|
Speech Perception | 3 | 2016 | 28 | 1.070 |
Why?
|
Face | 7 | 2012 | 26 | 0.950 |
Why?
|
Fabaceae | 4 | 2019 | 15 | 0.930 |
Why?
|
Memory | 5 | 2018 | 73 | 0.890 |
Why?
|
Psychological Theory | 5 | 2011 | 30 | 0.880 |
Why?
|
Humans | 54 | 2025 | 28121 | 0.850 |
Why?
|
Psychomotor Performance | 4 | 2019 | 72 | 0.840 |
Why?
|
Evoked Potentials | 2 | 2020 | 49 | 0.810 |
Why?
|
Anemia, Iron-Deficiency | 7 | 2023 | 27 | 0.790 |
Why?
|
Decision Making | 6 | 2021 | 173 | 0.780 |
Why?
|
Signal Detection, Psychological | 4 | 2011 | 8 | 0.770 |
Why?
|
Time Perception | 1 | 2021 | 3 | 0.760 |
Why?
|
Consciousness | 1 | 2021 | 6 | 0.710 |
Why?
|
Young Adult | 16 | 2022 | 2731 | 0.710 |
Why?
|
Music | 1 | 2020 | 2 | 0.690 |
Why?
|
Brain Waves | 1 | 2020 | 11 | 0.680 |
Why?
|
Temporal Lobe | 1 | 2020 | 32 | 0.670 |
Why?
|
Prefrontal Cortex | 1 | 2020 | 80 | 0.650 |
Why?
|
Affect | 1 | 2020 | 85 | 0.650 |
Why?
|
Contrast Sensitivity | 1 | 2019 | 3 | 0.640 |
Why?
|
Behavior | 1 | 2019 | 14 | 0.630 |
Why?
|
Female | 32 | 2025 | 15156 | 0.630 |
Why?
|
Potassium Compounds | 2 | 2017 | 4 | 0.600 |
Why?
|
Iodates | 2 | 2017 | 11 | 0.600 |
Why?
|
Ferrous Compounds | 2 | 2017 | 17 | 0.590 |
Why?
|
Adult | 21 | 2025 | 7757 | 0.560 |
Why?
|
Sodium Chloride | 1 | 2017 | 65 | 0.550 |
Why?
|
Discrimination Learning | 4 | 2005 | 8 | 0.550 |
Why?
|
Electroencephalography | 6 | 2019 | 136 | 0.540 |
Why?
|
Iron, Dietary | 5 | 2017 | 16 | 0.530 |
Why?
|
Energy Metabolism | 1 | 2017 | 198 | 0.500 |
Why?
|
Adolescent | 12 | 2023 | 3123 | 0.470 |
Why?
|
Psychology | 2 | 2004 | 19 | 0.450 |
Why?
|
Association Learning | 1 | 2013 | 9 | 0.430 |
Why?
|
Orientation | 5 | 2015 | 15 | 0.430 |
Why?
|
Photic Stimulation | 5 | 2016 | 67 | 0.420 |
Why?
|
Facial Expression | 2 | 2012 | 17 | 0.410 |
Why?
|
Psychophysics | 7 | 2021 | 10 | 0.410 |
Why?
|
Mental Recall | 5 | 2007 | 45 | 0.390 |
Why?
|
Social Perception | 1 | 2012 | 23 | 0.390 |
Why?
|
Male | 20 | 2022 | 13487 | 0.380 |
Why?
|
Field Dependence-Independence | 1 | 2011 | 1 | 0.370 |
Why?
|
Ferritins | 6 | 2022 | 27 | 0.360 |
Why?
|
Cyprinidae | 1 | 2010 | 4 | 0.340 |
Why?
|
Social Media | 2 | 2022 | 56 | 0.320 |
Why?
|
Water Pollutants, Chemical | 1 | 2010 | 55 | 0.320 |
Why?
|
Pennisetum | 3 | 2018 | 3 | 0.300 |
Why?
|
Double-Blind Method | 6 | 2019 | 414 | 0.300 |
Why?
|
Mental Processes | 2 | 2006 | 16 | 0.290 |
Why?
|
Vaping | 2 | 2022 | 129 | 0.290 |
Why?
|
Facial Recognition | 2 | 2018 | 4 | 0.270 |
Why?
|
India | 5 | 2018 | 143 | 0.260 |
Why?
|
Electronic Nicotine Delivery Systems | 2 | 2022 | 204 | 0.260 |
Why?
|
Aging | 1 | 2014 | 976 | 0.260 |
Why?
|
Form Perception | 1 | 2006 | 1 | 0.250 |
Why?
|
Acoustic Stimulation | 2 | 2016 | 30 | 0.240 |
Why?
|
Perimenopause | 1 | 2025 | 6 | 0.240 |
Why?
|
Probability | 2 | 2020 | 78 | 0.230 |
Why?
|
Rwanda | 3 | 2019 | 7 | 0.230 |
Why?
|
Nutritional Status | 4 | 2018 | 77 | 0.220 |
Why?
|
Lens Plant | 1 | 2023 | 1 | 0.220 |
Why?
|
Memory, Short-Term | 2 | 2005 | 62 | 0.220 |
Why?
|
RNA | 1 | 2024 | 111 | 0.200 |
Why?
|
Middle Aged | 7 | 2025 | 7164 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 411 | 0.200 |
Why?
|
Edible Grain | 1 | 2022 | 6 | 0.200 |
Why?
|
Electrophysiology | 1 | 2022 | 150 | 0.190 |
Why?
|
Healthy Aging | 1 | 2022 | 5 | 0.190 |
Why?
|
Memory, Episodic | 1 | 2022 | 18 | 0.190 |
Why?
|
Neurological Rehabilitation | 1 | 2021 | 3 | 0.180 |
Why?
|
Perceptual Distortion | 3 | 2015 | 3 | 0.180 |
Why?
|
Stroke Rehabilitation | 1 | 2021 | 13 | 0.180 |
Why?
|
Physical Therapists | 1 | 2021 | 12 | 0.180 |
Why?
|
Reference Values | 2 | 2011 | 200 | 0.180 |
Why?
|
Comprehension | 1 | 2021 | 18 | 0.180 |
Why?
|
Space Perception | 1 | 2020 | 8 | 0.180 |
Why?
|
Uncertainty | 1 | 2020 | 25 | 0.170 |
Why?
|
Bayes Theorem | 1 | 2020 | 100 | 0.170 |
Why?
|
Receptors, Transferrin | 5 | 2018 | 18 | 0.160 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 26 | 0.150 |
Why?
|
Public Health | 1 | 2019 | 93 | 0.150 |
Why?
|
Sodium Chloride, Dietary | 2 | 2017 | 12 | 0.150 |
Why?
|
Verbal Learning | 2 | 1994 | 12 | 0.140 |
Why?
|
Farmers | 1 | 2017 | 4 | 0.140 |
Why?
|
Stroke | 1 | 2021 | 252 | 0.140 |
Why?
|
Energy Intake | 1 | 2017 | 69 | 0.140 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2019 | 144 | 0.140 |
Why?
|
DEET | 1 | 2016 | 1 | 0.130 |
Why?
|
Diptera | 1 | 2016 | 7 | 0.130 |
Why?
|
Horses | 1 | 2016 | 35 | 0.130 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 243 | 0.120 |
Why?
|
Models, Theoretical | 2 | 2008 | 134 | 0.120 |
Why?
|
Optical Illusions | 1 | 2015 | 1 | 0.120 |
Why?
|
Evoked Potentials, Visual | 1 | 2015 | 5 | 0.120 |
Why?
|
Hemoglobins | 4 | 2018 | 118 | 0.120 |
Why?
|
Dietary Supplements | 1 | 2017 | 239 | 0.120 |
Why?
|
Linear Models | 3 | 2015 | 203 | 0.120 |
Why?
|
Speech Intelligibility | 1 | 1994 | 3 | 0.120 |
Why?
|
Problem Solving | 3 | 2008 | 28 | 0.110 |
Why?
|
Crops, Agricultural | 1 | 2014 | 19 | 0.110 |
Why?
|
Vitamin A | 1 | 2014 | 25 | 0.110 |
Why?
|
Diet | 1 | 2016 | 231 | 0.110 |
Why?
|
Iodine | 1 | 2014 | 11 | 0.110 |
Why?
|
Audiovisual Aids | 1 | 2014 | 13 | 0.110 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 82 | 0.110 |
Why?
|
Chlorambucil | 1 | 2014 | 2 | 0.110 |
Why?
|
Antigens, CD20 | 1 | 2014 | 3 | 0.110 |
Why?
|
Concept Formation | 2 | 2011 | 7 | 0.110 |
Why?
|
Treatment Outcome | 5 | 2019 | 2380 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 44 | 0.110 |
Why?
|
Cognitive Dysfunction | 1 | 2017 | 272 | 0.100 |
Why?
|
Child | 4 | 2023 | 2242 | 0.090 |
Why?
|
Fear | 1 | 2011 | 60 | 0.090 |
Why?
|
Aged | 3 | 2019 | 5416 | 0.090 |
Why?
|
Anxiety | 1 | 2011 | 146 | 0.080 |
Why?
|
Congresses as Topic | 2 | 2024 | 35 | 0.080 |
Why?
|
Rivers | 1 | 2010 | 16 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2010 | 51 | 0.080 |
Why?
|
Ecology | 1 | 2010 | 49 | 0.080 |
Why?
|
Computer Simulation | 2 | 2004 | 230 | 0.080 |
Why?
|
Health Status | 1 | 2010 | 148 | 0.080 |
Why?
|
Fixation, Ocular | 1 | 2008 | 3 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 2 | 2025 | 825 | 0.080 |
Why?
|
Brain Mapping | 2 | 2022 | 201 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2010 | 656 | 0.070 |
Why?
|
Risk Assessment | 1 | 2010 | 611 | 0.070 |
Why?
|
Aptitude | 1 | 2007 | 3 | 0.070 |
Why?
|
Gestalt Theory | 1 | 2006 | 1 | 0.070 |
Why?
|
Motivation | 1 | 2008 | 213 | 0.070 |
Why?
|
Rituximab | 2 | 2019 | 63 | 0.070 |
Why?
|
Indiana | 1 | 2006 | 13 | 0.070 |
Why?
|
Biomarkers | 1 | 2010 | 755 | 0.060 |
Why?
|
Psychological Tests | 1 | 2006 | 21 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2016 | 92 | 0.060 |
Why?
|
Stochastic Processes | 1 | 2004 | 10 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 58 | 0.060 |
Why?
|
Animals | 3 | 2016 | 10399 | 0.050 |
Why?
|
Bangladesh | 1 | 2023 | 14 | 0.050 |
Why?
|
Drug Industry | 1 | 2024 | 14 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2003 | 27 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2004 | 226 | 0.050 |
Why?
|
Bias | 1 | 2002 | 42 | 0.050 |
Why?
|
Natural Language Processing | 1 | 2022 | 17 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2015 | 1014 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2002 | 390 | 0.050 |
Why?
|
Neural Pathways | 1 | 2022 | 120 | 0.050 |
Why?
|
Nerve Net | 1 | 2022 | 106 | 0.040 |
Why?
|
Age Distribution | 1 | 2019 | 73 | 0.040 |
Why?
|
Immunoconjugates | 1 | 2019 | 21 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 194 | 0.040 |
Why?
|
Recurrence | 1 | 2019 | 323 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2017 | 16 | 0.040 |
Why?
|
Tea | 1 | 2017 | 7 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 167 | 0.040 |
Why?
|
Amnesia | 1 | 2017 | 9 | 0.040 |
Why?
|
Judgment | 2 | 2008 | 31 | 0.030 |
Why?
|
Women's Health | 1 | 2017 | 59 | 0.030 |
Why?
|
Prognosis | 1 | 2019 | 803 | 0.030 |
Why?
|
Insect Repellents | 1 | 2016 | 1 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 6 | 0.030 |
Why?
|
Students | 1 | 2018 | 196 | 0.030 |
Why?
|
Conditioning, Classical | 1 | 1996 | 12 | 0.030 |
Why?
|
Anemia | 1 | 2016 | 43 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 494 | 0.030 |
Why?
|
Body Mass Index | 1 | 2017 | 398 | 0.030 |
Why?
|
Behavior, Animal | 1 | 1996 | 107 | 0.030 |
Why?
|
Orosomucoid | 1 | 2015 | 4 | 0.030 |
Why?
|
Prosopagnosia | 1 | 2015 | 1 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2015 | 10 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2016 | 102 | 0.030 |
Why?
|
Manihot | 1 | 2014 | 1 | 0.030 |
Why?
|
Paired-Associate Learning | 1 | 1994 | 6 | 0.030 |
Why?
|
Asia | 1 | 2014 | 20 | 0.030 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2014 | 6 | 0.030 |
Why?
|
Zea mays | 1 | 2014 | 9 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 32 | 0.030 |
Why?
|
Oryza | 1 | 2014 | 40 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 112 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2015 | 134 | 0.030 |
Why?
|
Remission Induction | 1 | 2014 | 53 | 0.030 |
Why?
|
Anthropometry | 1 | 2014 | 94 | 0.030 |
Why?
|
Micronutrients | 1 | 2014 | 48 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 42 | 0.030 |
Why?
|
Age Factors | 1 | 1996 | 733 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 1994 | 62 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2014 | 238 | 0.030 |
Why?
|
Comorbidity | 1 | 2014 | 256 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 385 | 0.020 |
Why?
|
Rats | 1 | 1996 | 1564 | 0.020 |
Why?
|
Infant | 1 | 1996 | 996 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 2557 | 0.020 |
Why?
|
Child, Preschool | 1 | 1996 | 1137 | 0.020 |
Why?
|
Happiness | 1 | 2011 | 7 | 0.020 |
Why?
|
Personality Inventory | 1 | 2011 | 26 | 0.020 |
Why?
|
Eye Movements | 1 | 2011 | 12 | 0.020 |
Why?
|
Anger | 1 | 2011 | 15 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 1249 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 1994 | 773 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2014 | 2021 | 0.020 |
Why?
|
Mice | 1 | 1996 | 4645 | 0.020 |
Why?
|